Garrett Rossi, MD.

Research Update

Does Cannabis Legalization Increase the Risk of Driving-Related Injury?

July 1, 2024

Garrett Rossi, MD. Dr. Rossi has no financial relationships with companies related to this material.

Everyone knows that it is dangerous to drive while under the influence of alcohol—but what about cannabis? This study adds to a growing body of evidence that cannabis can be hazardous to safety on the road, a particularly important message to get out to patients as legalization becomes increasingly common.

Clinical Update

New Medications for Insomnia

February 1, 2024

Garrett Rossi, MD.

Garrett Rossi, MD. Inpatient/Consult Attending Psychiatrist, AtlantiCare Regional Medical Center, Pomona, NJ.
Dr. Rossi has no financial relationships with companies related to this material.

The orexin antagonist—daridorexant, lemborexant, and suvorexant—may be safer than traditional hypnotics, but how well do they work?

CARLAT WEBINAR

Insomnia Treatment Update

November 14, 2023

Garrett Rossi, MD.

0.50 CME Credits. We no longer recommend medications as first-line treatment. Here are the current pharmacotherapy approaches for the treatment of insomnia. Here are the indications for the use of benzodiazepines, non-benzodiazepines, and sedating antidepressants, and we're going to understand the mechanism of action and how to use the newest medications, orexin antagonists.

CARLAT WEBINAR

Psychedelics In Psychiatric Practice

September 12, 2023

Garrett Rossi, MD.

0.50 CME Credits. Despite limitations in current depression and PTSD treatments, there is a renewed interest in the therapeutic potential of these medications, which we'll explore in this webinar.

Clinical Update

A Psychedelic Primer

June 1, 2023

Chris Aiken, MD and Garrett Rossi, MD.

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Garrett Rossi, MD. Inpatient/Consult Attending Psychiatrist, AtlantiCare Regional Medical Center, Pomona, NJ.

The authors have no financial relationships with companies related to this material.

How did a dangerous drug of abuse become a therapeutic panacea?

CARLAT WEBINAR

Treating Depression Collaboratively

April 21, 2023

Garrett Rossi, MD.

0.50 CME Credits. Discover how primary care providers can effectively treat depression with the help of guidelines and algorithms, and learn when to refer patients to a psychiatrist in this informative webinar.

Clinical Update

The Medical Evaluation of Anorexia

February 1, 2023

Chris Aiken, MD and Garrett Rossi, MD.

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.
Garrett Rossi, MD. Adult psychiatrist, AtlantiCare Regional Medical Center, Pomona, NJ.

Dr. Aiken and Dr. Rossi have no financial relationships with companies related to this material.

When do you order labs, how do you weight patients, and what signs and symptoms should prompt a higher level of care?

Clinical Update

Anorexia: An Update for the Psychopharmacologist

January 31, 2023

Chris Aiken, MD and Garrett Rossi, MD.

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.
Garrett Rossi, MD. Adult psychiatrist, AtlantiCare Regional Medical Center, Pomona, NJ.

Dr. Aiken and Dr. Rossi have no financial relationships with companies related to this material.

A half-dozen reviews have concluded that no medication is effective for anorexia. We agree, but they may have overlooked a common supplement with evidence to help: Zinc.

CLINICAL UPDATE

Management of Depression and Neurocognitive Impairment in Patients With HIV

January 2, 2023

Garrett Rossi, MD.

Garrett Rossi, MD. Inpatient/consult attending psychiatrist, AtlantiCare Regional Medical Center. Pomona, NJ.
Dr. Rossi has no financial relationships with companies related to this material.

Strategies for HIV-associated mood and cognitive changes